Cephalosporin Drugs Market to increase rapidly by 2023
Industry Outlook and Trend Analysis: The Global Cephalosporin Drugs Market has observed considerable growth in the recent years and is foreseen to encounter significant growth in the upcoming years. Cephalosporin is a bactericidal β-lactam anti-microbial, which is used to regard bacterial diseases, for example, skin infections, staph infections, pneumonia, bronchitis, gonorrhoea, tonsillitis, otitis media, and strep throat. Competitive Insights: The leading players in the market are Eli Lilly and Company, Lupin Limited, Sanofi, Allergan, GlaxoSmithKline, Merck & Co, Pfizer, Teva Pharmaceutical Industries, Roche Holding AG and Bristol-Myers Squibb. The Cephalosporin Drugs Market is segmented as follows- By Generation: First-generation Cephalosporin Second-generation Cephalosporin Third-generation Cephalosporin Fourth-generation Cephalosporin Fifth-generation Cephalosporin By Type: Generics Branded By Route of Drug Administra...